PT  - JOURNAL ARTICLE
AU  - Pedro Guimarães
AU  - Andreas Keller
AU  - Michael Böhm
AU  - Lucas Lauder
AU  - José L. Ayala
AU  - José R. Banegas
AU  - Alejandro de la Sierra
AU  - Ernest Vinyoles
AU  - Manuel Gorostidi
AU  - Julián Segura
AU  - Gema Ruiz-Hurtado
AU  - Luis M. Ruilope
AU  - Felix Mahfoud
TI  - Risk prediction with office and ambulatory blood pressure using artificial intelligence
AID  - 10.1101/2020.01.17.20017798
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.01.17.20017798
4099  - http://medrxiv.org/content/early/2020/02/12/2020.01.17.20017798.short
4100  - http://medrxiv.org/content/early/2020/02/12/2020.01.17.20017798.full
AB  - The authors have withdrawn this manuscript because they became aware of inaccuracies on the original raw data. Once these issues are resolved the data will be re-analyzed. However, for now, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementFelix Mahfoud received speaker honoraria from Medtronic, Recor, Berlin Chemie and Boehringer Ingelheim, and is supported Deutsche Gesellschaft für Kardiologie and Deutsche Forschungsgemeinschaft (SFB TRR219). Michael Böhm reports support from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cytokinetics, Servier, Medtronic, Novartis and Vifor. MB is supported by the Deutsche Forschungsgemeinschaft (DFG, TTR SFB- 219, S-01, M-03, M-05). All other authors report no conflict of interest.Funding StatementFelix Mahfoud and Michael Böhm received supported by Deutsche Gesellschaft für Kardiologie and Deutsche Forschungsgemeinschaft (SFB TRR219).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes